InvestorsHub Logo
Followers 1
Posts 972
Boards Moderated 0
Alias Born 02/14/2018

Re: mm2k post# 81120

Wednesday, 09/12/2018 5:45:39 PM

Wednesday, September 12, 2018 5:45:39 PM

Post# of 108192
No major news. They started their p1 trials before us. They're a neoantigen play, which is why people have used their IPO as a comparison in complaining that our mk cap is way too low. I honestly don't know if their approach is any better/worse than ours. Just interesting to see how WS is pricing this new way of combatting cancer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News